Not All Patients Start From the Same Line: Rethinking Outcome Interpretation in Myasthenia Gravis

Authors

Christian Messina (ORCID: https://orcid.org/0000-0003-3027-7863)

Publication Details

Journal: Clinical and Experimental Neuroimmunology
Published: 2025-09-16
DOI: https://doi.org/10.1111/cen3.70027
Citations: 1
Primary Topic: Myasthenia Gravis and Thymoma
Type: article
Field-Weighted Citation Impact: 1.39

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Not All Patients Start From the Same Line: Rethinking Outcome Interpretation in Myasthenia Gravis

Christian Messina

Sep 16, 2025

1 citations

Clinical and Experimental Neuroimmunology

Myasthenia Gravis and Thymoma

1.39

article

Not All Patients Start From the Same Line: Rethinking Outcome Interpretation in Myasthenia Gravis

Christian Messina

September 16, 2025article en

1 citations

Abstract

No abstract available for this paper.

Clinical and Experimental NeuroimmunologyVol. 17(1)

Openalex Percentile: Top 16%

Myasthenia Gravis and Thymoma

1.39

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Not All Patients Start From the Same Line: Rethinking Outcome Interpretation in Myasthenia Gravis — Christian Messina · Clinical and Experimental Neuroimmunology (2025) | TGRS Research Map | TGRS